Evidence map›Paper›PMID 38071535›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2024

Tumor Location Relative to the Spleen Is a Prognostic Factor in Lymphoma Patients: A Demonstration from the REMARC Trial.

Kibrom B Girum, Anne-Ségolène Cottereau, Laetitia Vercellino, Louis Rebaud, Jérôme Clerc, Olivier Casasnovas, Franck Morschhauser, Catherine Thieblemont, Irène Buvat

Abstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Summary Report of the SNMMI AI Task Force Radiomics Challenge 2024.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
  5. Prognostic value of early post-treatmentCancer imaging : the official publication of the International Cancer Imaging Society · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kibrom B GirumLITO Laboratory, U1288 Inserm, Institut Curie, University Paris-Saclay, Orsay, France.
Anne-Ségolène CottereauDepartment of Nuclear Medicine, Cochin Hospital, AP-HP, Paris Descartes University, Paris, France.
Laetitia VercellinoDepartment of Nuclear Medicine, Saint Louis Hospital, AP-HP, Paris, France.
Louis RebaudLITO Laboratory, U1288 Inserm, Institut Curie, University Paris-Saclay, Orsay, France.
Jérôme ClercDepartment of Nuclear Medicine, Cochin Hospital, AP-HP, Paris Descartes University, Paris, France.
Olivier CasasnovasDepartment of Hematology, University Hospital of Dijon, Dijon, France.
Franck MorschhauserResearch Group on Injectable Forms and Associated Technologies, Department of Hematology, Claude Huriez Hospital, University Lille, Lille, France; and.
Catherine ThieblemontDepartment of Hematology, Saint Louis Hospital, AP-HP, Paris, France.
Irène BuvatLITO Laboratory, U1288 Inserm, Institut Curie, University Paris-Saclay, Orsay, France; irene.buvat@curie.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Baseline [

Indexed as

Lymphoma, Large B-Cell, DiffusePositron Emission Tomography Computed TomographyAgedArtificial IntelligenceFluorodeoxyglucose F18HumansMaleMiddle AgedPrognosisRetrospective StudiesSpleenTumor BurdenFluorodeoxyglucose F18artificial intelligenceCTDLBCLFDGtumor location

Identifiers

PMID38071535
PMCPMC10858380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.